BioCatalyst

ABT-101 — catalyst calendar

1 verified catalyst event(s) referencing ABT-101, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11 (month)
in 3mo
ESTIMATED
 READOUT
Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients
Phase 1/2 · Advanced Solid Tumor, Non Small Cell Lung Cancer
 Anbogen Therapeutics, Inc. ABT-101 ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.